3.不建议环磷酰胺用于哺乳期患者(2C,99.7%)。 参考文献:Russell MD, Dey M, Flint J,et al. British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs ...
Medical management of women with rheumatic diseases during pregnancy is challenging owing to incomplete information regarding medication safety. The British Society for Rheumatology and the British Health Professionals in Rheumatology committee published consensus guidelines that provide a good first step ...
内容提示: GuidelinesBritish Society for Rheumatology guideline onprescribing drugs in pregnancy and breastfeeding:immunomodulatory anti-rheumatic drugs andcorticosteroidsMark D. Russell1 , Mrinalini Dey 2 , Julia Flint 3 , Philippa Davie 1 , Alexander Allen 4 , Amy Crossley 5 ,Margreta Frishman 6 ...
In addi- tion, we verified the validity of the predicted FZHY targets that may regulate the associated pathways. Material and methods Drugs, chemicals, and animal administration Wistar rats (150–160 g) were purchased from the Shanghai Laboratory Animal Center of the Chinese Academy of Sci- ...
参考文献:Russell MD, Dey M, Flint J,et al. British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids[J]. Rheumatology (Oxford). ...